Contact dermatitis to levobunolol eyedrops superimposed on IgE-mediated rhinoconjunctivitis.
Blumetti
Brooke
B
Brodell
Robert T
RT
Helms
Stephen E
SE
Brodell
Linda P
LP
Bredle
Donald L
DL
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D000368:Aged; D015897:Comorbidity; D003231:Conjunctivitis / Q000175:diagnosis; D017449:Dermatitis, Allergic Contact / Q000175:diagnosis / Q000209:etiology*; D005901:Glaucoma / Q000188:drug therapy; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology; D002040:Levobunolol / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D009883:Ophthalmic Solutions; D012220:Rhinitis / Q000175:diagnosis
D000319:Adrenergic beta-Antagonists; D009883:Ophthalmic Solutions; D007073:Immunoglobulin E; D002040:Levobunolol